ABOUT RESEARCH
CONTENTS

In order to enhance the inherent self-regenerative potential of the human body and to restore tissues and organs injury, we are developing new biological materials that are non-invasive and gentle on the body. For this purpose, the technology we are promoting is called “decellularization”. This technology efficiently generates native organ derived extracellular matrix containing a large amount of collagen as well as bio-active molecules that are effective for tissue regeneration.

ABOUT MATRISURGE

Profile / Staff

Based on the research results of Keio University School of Medicine, Tokyo Metropolitan Advanced Medical Device Acceleration Project “AMDAP”
With support from JSR / Keio University Medical and Chemical Innovation Center `` JKiC ''
Established as a university venture.

Company Profile

Challenge to advanced medicine. In the unknown field of regenerative medicine, we will develop a completely different method.

INFORMATION

• 2023.10.21 Results announced: Presented at the 49th Academic Meeting of the Japan Society for Organ Preservation and Biology. MORE READ
• 2023.09.26 Progress status: Non-clinical safety studies have started MORE READ
• 2023.08.28 Results announced: Presented at “The 18th Congress of Asian Society of Transplantation” held in Hong Kong MORE READ